111 related articles for article (PubMed ID: 24309227)
1. Association of serum YKL-40 levels with the presence and severity of coronary artery disease in patients with obstructive sleep apnea syndrome.
Sui X; Gao C
Clin Invest Med; 2013 Dec; 36(6):E306-11. PubMed ID: 24309227
[TBL] [Abstract][Full Text] [Related]
2. Association of serum YKL-40 with the presence and severity of obstructive sleep apnea syndrome.
Li W; Yu Z; Jiang C
Lab Med; 2014; 45(3):220-5. PubMed ID: 25051073
[TBL] [Abstract][Full Text] [Related]
3. Serum YKL-40 concentrations are elevated and correlated with disease severity in patients with obstructive sleep apnea syndrome.
Wang X; Xing GH
Scand J Clin Lab Invest; 2014 Jan; 74(1):74-8. PubMed ID: 24405178
[TBL] [Abstract][Full Text] [Related]
4. Serum YKL-40 levels are associated with type 2 diabetes mellitus in patients with obstructive sleep apnea syndrome.
Sun L; Liu JY; Li LR
Genet Mol Res; 2015 Aug; 14(3):8919-25. PubMed ID: 26345823
[TBL] [Abstract][Full Text] [Related]
5. Serum YKL-40/chitinase 3-like protein 1 level is an independent predictor of atherosclerosis development in patients with obstructive sleep apnea syndrome.
Bakırcı EM; Ünver E; Değirmenci H; Kıvanç T; Günay M; Hamur H; Büyüklü M; Ceyhun G; Topal E; Çoban TA
Turk Kardiyol Dern Ars; 2015 Jun; 43(4):333-9. PubMed ID: 26142786
[TBL] [Abstract][Full Text] [Related]
6. YKL-40: may be use as a new inflammatory biomarker in obstructive sleep apnea syndrome?
Duru S; Yüce G; Fırat H; Şimşek B; Uçar F; Ardıç S; Kurt EB
Tuberk Toraks; 2015 Sep; 63(3):158-64. PubMed ID: 26523896
[TBL] [Abstract][Full Text] [Related]
7. Serum YKL-40 level is correlated with apnea hypopnea index in patients with obstructive sleep apnea sindrome.
Mutlu LC; Tülübaş F; Alp R; Kaplan G; Yildiz ZD; Gürel A
Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4161-4166. PubMed ID: 29028081
[TBL] [Abstract][Full Text] [Related]
8. Plasma YKL-40 in relation to the degree of coronary artery disease in patients with stable ischemic heart disease.
Mathiasen AB; Harutyunyan MJ; Jørgensen E; Helqvist S; Ripa R; Gøtze JP; Johansen JS; Kastrup J
Scand J Clin Lab Invest; 2011 Sep; 71(5):439-47. PubMed ID: 21827355
[TBL] [Abstract][Full Text] [Related]
9. Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus.
Kim HM; Lee BW; Song YM; Kim WJ; Chang HJ; Choi DH; Yu HT; Kang E; Cha BS; Lee HC
Cardiovasc Diabetol; 2012 Jul; 11():84. PubMed ID: 22809439
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population.
Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF
Cytokine; 2011 Apr; 54(1):51-5. PubMed ID: 21257319
[TBL] [Abstract][Full Text] [Related]
11. Increased YKL-40 levels in patients with isolated coronary artery ectasia: an observational study.
Erdoğan T; Kocaman SA; Çetin M; Durakoğlugil ME; Kırbaş A; Canga A; Yılmaz A; Doğan S; Çiçek Y
Anadolu Kardiyol Derg; 2013 Aug; 13(5):465-70. PubMed ID: 23728225
[TBL] [Abstract][Full Text] [Related]
12. Serum YKL-40 levels in patients with coronary artery disease.
Kucur M; Isman FK; Karadag B; Vural VA; Tavsanoglu S
Coron Artery Dis; 2007 Aug; 18(5):391-6. PubMed ID: 17627189
[TBL] [Abstract][Full Text] [Related]
13. Increased serum YKL-40 and C-reactive protein levels are associated with angiographic lesion progression in patients with coronary artery disease.
Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF
Atherosclerosis; 2010 Jun; 210(2):590-5. PubMed ID: 20056225
[TBL] [Abstract][Full Text] [Related]
14. Serum YKL-40 predicts long-term mortality in patients with stable coronary disease: a prognostic study within the CLARICOR trial.
Harutyunyan M; Gøtze JP; Winkel P; Johansen JS; Hansen JF; Jensen GB; Hilden J; Kjøller E; Kolmos HJ; Gluud C; Kastrup J
Immunobiology; 2013 Jul; 218(7):945-51. PubMed ID: 23294528
[TBL] [Abstract][Full Text] [Related]
15. Serum YKL-40 for monitoring myocardial ischemia after revascularization in patients with stable coronary artery disease.
Harutyunyan M; Johansen JS; Mygind ND; Reuter SB; Kastrup J
Biomark Med; 2014; 8(8):977-87. PubMed ID: 25343670
[TBL] [Abstract][Full Text] [Related]
16. High serum YKL-40 level positively correlates with coronary artery disease.
Jin Y; Cao JN; Wang CX; Feng QT; Ye XH; Xu X; Yang CJ
Biomark Med; 2017 Feb; 11(2):133-139. PubMed ID: 28097894
[TBL] [Abstract][Full Text] [Related]
17. Increased plasma YKL-40/chitinase-3-like-protein-1 is associated with endothelial dysfunction in obstructive sleep apnea.
Jafari B; Elias JA; Mohsenin V
PLoS One; 2014; 9(5):e98629. PubMed ID: 24878721
[TBL] [Abstract][Full Text] [Related]
18. Association of serum hepcidin levels with the presence and severity of obstructive sleep apnea syndrome.
Liu Y; Yu Z; Hua D; Chen Y; Zheng S; Wang L
Med Sci Monit; 2015 Jan; 21():27-31. PubMed ID: 25553801
[TBL] [Abstract][Full Text] [Related]
19. Decreased levels of serum omentin-1 in patients with obstructive sleep apnoea syndrome.
Wang Q; Feng X; Zhou C; Li P; Kang J
Ann Clin Biochem; 2013 May; 50(Pt 3):230-5. PubMed ID: 23605136
[TBL] [Abstract][Full Text] [Related]
20. Galectin-3 is associated with coronary plaque burden and obstructive sleep apnoea syndrome severity.
Pusuroglu H; Somuncu U; Bolat I; Akgul O; Ornek V; Yıldırım HA; Akkaya E; Karakurt H; Yıldırım A; Savaş AU
Kardiol Pol; 2017; 75(4):351-359. PubMed ID: 28150280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
